Statera Biopharma, Inc.
Statera Biopharma, Inc. (STAB) Net Income & Profit History
Annual & trailing net income, net margin, YoY change, and peer profitability context.
STAB · net income · updated Jun 9, 2026
Core profitability metrics
STAB · net income · margin · TTM · CAGRNet income was −$174.4M for FY2021 (fiscal year ending 2021-12-31), down 1218.8% year-over-year. Net profit margin was —. Based on available data, Statera Biopharma, Inc. has been profitable since at least 2014.
Annual net income history
▸ FMP /income-statement · Annual · STAB net income history · STAB profit margin
Annual net income data
Net income vs peers (Healthcare)
About Net Income & Methodology
Statera Biopharma, Inc. (STAB) reported net income of −$174.4M for FY2021 (fiscal year ending 2021-12-31), down 1218.8% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.
Based on available data, Statera Biopharma, Inc. has been profitable since at least 2014. Net income reached a peak of $1.63B in FY2014. Data available for 15 fiscal years.
Statera Biopharma, Inc.'s net profit margin was — for FY2021, based on the latest annual results.
Investors sometimes search for "Statera Biopharma, Inc. net worth" — the company's market capitalization is a separate figure from STAB net income. Data sourced from FMP /income-statement · US GAAP · USD.
Frequently asked questions
STAB net income · 4 questionsStatera Biopharma, Inc. is not currently profitable on an annual basis. The company reported a net loss of $174.4M for FY2021.
▸ Source: FMP /income-statement · GAAP · Statera Biopharma, Inc. · Statera Biopharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026